<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03094806</url>
  </required_header>
  <id_info>
    <org_study_id>470455</org_study_id>
    <nct_id>NCT03094806</nct_id>
  </id_info>
  <brief_title>Vibratory PEP Device and Hospital Length of Stay for Acute Exacerbation of COPD</brief_title>
  <official_title>Vibratory/Positive Expiratory Pressure Device and Hospital Length of Stay for Acute Exacerbation of Chronic Obstructive Pulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York Methodist Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>New York Methodist Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is evaluating the use of a respiratory device, the Acapella Vibratory Positive
      Expiratory Pressure (PEP) Therapy device, in patients admitted to the hospital with a chronic
      obstructive pulmonary disease (COPD) exacerbation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators hypothesize that the PEP-FV used as adjunctive therapy in patients
      hospitalized for an acute exacerbation of COPD will result in decreased hospital length of
      stay and improvement of overall COPD-related health outcomes.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">October 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Length of Stay</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Time of admission to time of discharge from hospital</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Analysis of Change in Daily Sputum Production</measure>
    <time_frame>Up to 5 days</time_frame>
    <description>Sputum production in a 24 hour period in mL volume</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea on the Borg Scale</measure>
    <time_frame>Up to 5 days</time_frame>
    <description>Scale is used to rate the difficulty of breathing. It starts at 0 where the breathing is causing no difficulty at all and progresses through to number 10 where the breathing difficulty is maximal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Dyspnea on the MMRC Scale</measure>
    <time_frame>Up to 5 days</time_frame>
    <description>The Modified Medical Research Council (MMRC) dyspnea scale is used to assess an individual's shortness of breath. It starts at 0 where the shortness of breath occurs during strenuous exercise and progresses through to number 4 where the shortness of breath is maximal.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 6MWT Test</measure>
    <time_frame>Day 1 and Day 5</time_frame>
    <description>A six-minute walk test (6MWT) measures the distance that an individual can walk on a flat, hard surface in a period of six minutes. This is used to assess the exercise tolerance measured by the difference in meters between the tests.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in Bedside Spirometry</measure>
    <time_frame>Day 5</time_frame>
    <description>Degree of airflow obstruction (FEV1/FVC)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In Hospital Mortality</measure>
    <time_frame>Up to 2 weeks</time_frame>
    <description>Death at the time of discharge</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">91</enrollment>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <arm_group>
    <arm_group_label>Acapella Vibratory PEP Therapy Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject will use the device 3 times a day throughout hospital stay</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Acapella Vibratory PEP Device</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subject will use the sham device 3 times a day throughout hospital stay</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Acapella Vibratory PEP Therapy Device plus usual care</intervention_name>
    <description>The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
    <arm_group_label>Acapella Vibratory PEP Therapy Device</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham Acapella Vibratory PEP Device plus usual care</intervention_name>
    <description>The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
    <arm_group_label>Sham Acapella Vibratory PEP Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admitted with COPD exacerbation as a primary diagnosis

          -  Subjectively produces more than 1 tablespoon (15 ml) / day of sputum

          -  Has the subjective feeling that he/she cannot cough up or clear her secretions

          -  Physical respiratory system exam by the physician with evidence of course ronchi
             suggestive of impacted secretions

          -  &gt; 10 pack-year smoking history

        Exclusion Criteria:

          -  Cannot use the flutter device or unable to follow commands

          -  Altered mental status

          -  Known active malignancy

          -  Known systolic congestive heart failure (CHF) with ejection fraction (EF) &lt; 40% or
             clinically in acute CHF exacerbation as documented by cardiologist or primary
             diagnosis other than COPD

          -  Pregnancy

          -  Patients in severe exacerbation (Intubated, Continuous use of NIPPV, Unable to speak
             full sentences)

          -  Intracranial pressure (ICP) &gt;20 mmHg

          -  Hemodynamic instability (requiring vasopressor support)

          -  Recent facial, oral, or skull surgery or trauma.

          -  Acute sinusitis.

          -  Epistaxis.

          -  Esophageal surgery.

          -  Active Hemoptysis (More than 2 tablespoons of frank blood per day)

          -  Nausea.

          -  Severe earache or discharge from ear. (Known or suspected tympanic membrane rupture or
             other middle ear pathology)

          -  Untreated pneumothorax.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy A Weingarten, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York Methodist Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New York Methodist Hospital</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11215</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2018</verification_date>
  <study_first_submitted>May 27, 2015</study_first_submitted>
  <study_first_submitted_qc>March 23, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 29, 2017</study_first_posted>
  <results_first_submitted>December 21, 2017</results_first_submitted>
  <results_first_submitted_qc>September 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">October 11, 2018</results_first_posted>
  <last_update_submitted>September 12, 2018</last_update_submitted>
  <last_update_submitted_qc>September 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Acapella Vibratory PEP Therapy Device</title>
          <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
        </group>
        <group group_id="P2">
          <title>Sham Acapella Vibratory PEP Device</title>
          <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Acapella Vibratory PEP Therapy Device</title>
          <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
        </group>
        <group group_id="B2">
          <title>Sham Acapella Vibratory PEP Device</title>
          <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="44"/>
            <count group_id="B2" value="47"/>
            <count group_id="B3" value="91"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="28"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.8" spread="10.6"/>
                    <measurement group_id="B2" value="65.9" spread="12.2"/>
                    <measurement group_id="B3" value="64.0" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="58"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="31"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="29"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">not measured</measurement>
                    <measurement group_id="B2" value="NA">not measured</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="NA">not measured</measurement>
                    <measurement group_id="B2" value="NA">not measured</measurement>
                    <measurement group_id="B3" value="NA">Total not calculated because data are not available (NA) in one or more arms.</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="47"/>
                    <measurement group_id="B3" value="91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body Mass Index (BMI)</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.6" spread="11.9"/>
                    <measurement group_id="B2" value="30.7" spread="8.2"/>
                    <measurement group_id="B3" value="32.6" spread="10.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Length of Stay</title>
        <description>Time of admission to time of discharge from hospital</description>
        <time_frame>Up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Length of Stay</title>
          <description>Time of admission to time of discharge from hospital</description>
          <units>days</units>
          <param>Median</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.8" lower_limit="3.9" upper_limit="6.1"/>
                    <measurement group_id="O2" value="3.2" lower_limit="3.0" upper_limit="4.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Analysis of Change in Daily Sputum Production</title>
        <description>Sputum production in a 24 hour period in mL volume</description>
        <time_frame>Up to 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Analysis of Change in Daily Sputum Production</title>
          <description>Sputum production in a 24 hour period in mL volume</description>
          <units>volume in mL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Sputum production day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.6" spread="8.8"/>
                    <measurement group_id="O2" value="14.6" spread="17.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sputum production day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.5" spread="8.5"/>
                    <measurement group_id="O2" value="15.9" spread="16.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sputum production day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6.5" spread="6.7"/>
                    <measurement group_id="O2" value="15.9" spread="16.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sputum production day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.3" spread="7.0"/>
                    <measurement group_id="O2" value="13.4" spread="16.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sputum production day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="5.7"/>
                    <measurement group_id="O2" value="13.3" spread="15.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dyspnea on the Borg Scale</title>
        <description>Scale is used to rate the difficulty of breathing. It starts at 0 where the breathing is causing no difficulty at all and progresses through to number 10 where the breathing difficulty is maximal.</description>
        <time_frame>Up to 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Dyspnea on the Borg Scale</title>
          <description>Scale is used to rate the difficulty of breathing. It starts at 0 where the breathing is causing no difficulty at all and progresses through to number 10 where the breathing difficulty is maximal.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Borg scale day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.0" spread="2.4"/>
                    <measurement group_id="O2" value="5.1" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Borg scale day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.7" spread="2.1"/>
                    <measurement group_id="O2" value="4.3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Borg scale day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.3" spread="2.2"/>
                    <measurement group_id="O2" value="3.3" spread="2.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Borg scale day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.9" spread="2.1"/>
                    <measurement group_id="O2" value="3.3" spread="2.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Borg scale day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.1" spread="2.4"/>
                    <measurement group_id="O2" value="3.2" spread="2.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Dyspnea on the MMRC Scale</title>
        <description>The Modified Medical Research Council (MMRC) dyspnea scale is used to assess an individual's shortness of breath. It starts at 0 where the shortness of breath occurs during strenuous exercise and progresses through to number 4 where the shortness of breath is maximal.</description>
        <time_frame>Up to 5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Dyspnea on the MMRC Scale</title>
          <description>The Modified Medical Research Council (MMRC) dyspnea scale is used to assess an individual's shortness of breath. It starts at 0 where the shortness of breath occurs during strenuous exercise and progresses through to number 4 where the shortness of breath is maximal.</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>MMRC scale day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.2" spread="1.0"/>
                    <measurement group_id="O2" value="2.4" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MMRC scale day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.9" spread="1.0"/>
                    <measurement group_id="O2" value="2.1" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MMRC scale day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.0"/>
                    <measurement group_id="O2" value="2.2" spread="1.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MMRC scale day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.0"/>
                    <measurement group_id="O2" value="2.2" spread="1.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>MMRC scale day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.8" spread="1.0"/>
                    <measurement group_id="O2" value="2.4" spread="0.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in 6MWT Test</title>
        <description>A six-minute walk test (6MWT) measures the distance that an individual can walk on a flat, hard surface in a period of six minutes. This is used to assess the exercise tolerance measured by the difference in meters between the tests.</description>
        <time_frame>Day 1 and Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Change in 6MWT Test</title>
          <description>A six-minute walk test (6MWT) measures the distance that an individual can walk on a flat, hard surface in a period of six minutes. This is used to assess the exercise tolerance measured by the difference in meters between the tests.</description>
          <units>meters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>6MWT day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="168.8" spread="118.9"/>
                    <measurement group_id="O2" value="206.7" spread="120.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 MWT day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200.1" spread="90.3"/>
                    <measurement group_id="O2" value="199.3" spread="119.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Difference in Bedside Spirometry</title>
        <description>Degree of airflow obstruction (FEV1/FVC)</description>
        <time_frame>Day 5</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>Difference in Bedside Spirometry</title>
          <description>Degree of airflow obstruction (FEV1/FVC)</description>
          <units>ratio</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70.7" spread="20.6"/>
                    <measurement group_id="O2" value="57.7" spread="13.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>In Hospital Mortality</title>
        <description>Death at the time of discharge</description>
        <time_frame>Up to 2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Acapella Vibratory PEP Therapy Device</title>
            <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
          </group>
          <group group_id="O2">
            <title>Sham Acapella Vibratory PEP Device</title>
            <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
          </group>
        </group_list>
        <measure>
          <title>In Hospital Mortality</title>
          <description>Death at the time of discharge</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="44"/>
                <count group_id="O2" value="47"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Admission to discharge or Day 5, whichever occurred first.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Acapella Vibratory PEP Therapy Device</title>
          <description>Subject will use the device 3 times a day throughout hospital stay
Acapella Vibratory PEP Therapy Device plus usual care: The acapellaÂ® Vibratory PEP Therapy System (PEP-FV) device is a handheld device that operates in same principle as standard FV. Unlike standard FV, it is not gravity dependent. It comes in two different devices to accommodate for different flows rates of the patient. It has similar properties of a standard FV and may be better tolerated.</description>
        </group>
        <group group_id="E2">
          <title>Sham Acapella Vibratory PEP Device</title>
          <description>Subject will use the sham device 3 times a day throughout hospital stay
Sham Acapella Vibratory PEP Device plus usual care: The Sham Acapella Vibratory PEP Device is the same as the Therapy Device, except the flutter valve has been removed from the device.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="44"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="47"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Jeremy A Weingarten, MD</name_or_title>
      <organization>New York Methodist Hospital</organization>
      <phone>718-780-5835</phone>
      <email>jaw9031@nyp.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

